Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02413411 · ClinicalTrials.gov registry record · NA

Race and Preference for Knee Replacement: A Patient-Centered Intervention

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
493
Enrollment target

NCT02413411: Completed NA study, sponsored by University of Pennsylvania.

NCT02413411 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 493 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02413411, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
493 participants
Enrollment target

Study Summary

A randomized, controlled design will be utilized to examine and compare the effectiveness of the proposed educational intervention, which includes a combination of an educational decision aid and motivational interviewing with attention control on select key patient-centered and process of care outcomes. The study sample will consist of approximately 450 African-American patients with osteoarthritis of the knee. Patients will be recruited from the University of Pennsylvania Health System and the Philadelphia VA Medical Center and will be randomized to one of the two study arms. The immediate goal of this randomized controlled trial is to assess the effect of a high-quality, evidence-based, patient-centered educational intervention supplemented with targeted counseling (motivational interviewing) on African American patient preferences, expectations, and the likelihood of achieving a referral for surgical evaluation. The long-term goal of this research is to widely implement a patient-centered educational intervention targeting African Americans who are potential candidates for joint replacement, in a national effort to reduce and ultimately eliminate racial disparities in the utilization of this effective treatment option. Study Aim:To examine the effect of the knee osteoarthritis Decision Aid (DA)/Motivational Interviewing (MI) intervention on orthopedic surgery referral rates for African American (AA) patients. Hypothesis: Compared to attention control, the DA/MI intervention will lead to higher orthopedic surgery referral rates for AA patients. Secondary aim: To examine the effect of the DA/MI intervention on the rate of knee replacement receipt among AA patients. Hypothesis: AA patients randomized to receive the intervention will have higher rates of knee replacement compared to those in the attention control group.

Primary Outcome

Referral to knee joint replacement will be assessed for all patients 12 months post-intervention initially through telephone survey and then validated by medical record review

Interventions

  • BEHAVIORAL DA/MI Intervention
  • BEHAVIORAL an educational program (an NIH-developed booklet)

Trial Details

FieldValue
Enrollment Target 493 participants
Start Date 2010-05
Est. Completion 2014-05
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT02413411 record still lists

NCT02413411 is an interventional study that assigns participants to a tested intervention. The registered 493 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).

The record links to 0 conditions, and to 2 interventions - of which DA/MI Intervention is the first listed.

NCT02413411 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02413411 about?

NCT02413411 is a clinical study titled "Race and Preference for Knee Replacement: A Patient-Centered Intervention". A randomized, controlled design will be utilized to examine and compare the effectiveness of the proposed educational intervention, which includes a combination of an educational decision aid and motivational interviewing with attention control on select key patient-centered and process of care outc...

What is the current status of trial NCT02413411?

This trial is currently completed. It is a NA study. The enrollment target is 493 participants. The study started on 2010-05. Estimated completion is 2014-05.

What interventions are being tested in trial NCT02413411?

The interventions under investigation include: DA/MI Intervention (BEHAVIORAL), an educational program (an NIH-developed booklet) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02413411?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02413411's enrollment target sits among peer trials

493 213th of 2000 higher than 1,788 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05861973 · 492 participants · NA

    SMARTer Weight Loss Management

  • NCT05908331 · 492 participants · NA

    MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

  • NCT06152575 · 492 participants · Phase 3

    MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  • NCT06953089 · 492 participants · Phase 2

    DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02413411, the US trial registry maintained by the National Library of Medicine. NCT02413411 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.